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Research articles on atherosclerosis have been well
represented in The American Journal of Pathology
(AJP), with more than 500 articles published since
1925. An initial focus on descriptive studies led to the
proposal that atherosclerosis occurs as a response to
vascular injury. With time, this view was modified by
a greater understanding of the roles played by lipids
and integrity of the vessel wall’s constituent cells and
matrix. AJP has been a major contributor to the field,
publishing numerous seminal research papers and
review articles on the latest advances in atheroscle-
rosis. This Centennial Review highlights these myriad
contributions. (Am J Pathol 2012, 180:2184–2187; http://
dx.doi.org/10.1016/j.ajpath.2012.04.003)
Atherosclerosis is a recurring theme throughout the his-
tory of The American Journal of Pathology (AJP). More than
500 articles directly relating to the disease have been
published in the AJP since its debut in 1925; in fact, the
first issue featured a paper on the topic. Throughout the
next 25 years, however, the rate of publication averaged
only about one article per year. Instead, studies of infec-
tious diseases dominated, a reminder that in the prean-
tibiotic era, only a fortunate few avoided microbes long
enough to worry about heart disease. In these early
years, most of the articles on atherosclerosis centered on
examination of human lesions from autopsy specimens,
with a smattering of studies using rudimentary animal
models. The pace of publication in the field quickened in
the 1950s, aided by the introduction of electron microscopy
for dissection of the fine structure of atheromas and the
development of better techniques to analyze the contents of
2184plaques. Today, articles on vascular biology, atherosclero-
sis, and endothelial biology are so numerous that they merit
their own section in AJP’s Table of Contents.
The Response-to-Injury Theory
The “response-to-injury” hypothesis is now widely ac-
cepted as the mechanistic basis of the pathogenesis of
atherosclerosis, and it has helped to weave together the
many threads of research over the years. The idea that
atherosclerosis results from injury to arterial walls traces
back to Rudolph Virchow in 1856,1 but it took more than
a century before the basic molecular and cellular details
that constitute the modern view were established. Russell
Ross, a past president of the American Society for Inves-
tigative Pathology (ASIP) and a long-time member of the
AJP’s Editorial Board, first formulated the response-to-
injury theory with his colleague John Glomset in 19732
and elaborated on it in an AJP review article in 1977.3 In
essence, the hypothesis states that atherosclerosis be-
gins with injury to the endothelial lining of arteries. Al-
though injury was initially presumed to cause endothelial
denudation, subsequent experimentation has shown that
the damage can be very subtle, resulting in only dysfunc-
tion of the endothelium without overt loss. Such altered
endothelium recruits circulating mononuclear cells into the
arterial wall, where subsequent uptake of lipoproteins by the
leukocytes fosters their activation and sets the stage for a
chronic inflammatory response. Factors released by cells in
the developing lesion then promote influx and proliferation
of smooth muscle cells, as well as heightened synthesis of
extracellular matrix. The ultimate outcome is an intimal
plaque that insidiously encroaches on the vessel lumen and
may abruptly rupture, leading to thrombotic occlusion.
What, then, is the initial insult to the endothelium that
sets the whole process in motion? In an era of pervasive
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of statins), almost everyone, scientist or not, would likely
answer that at least a part of the equation is too much
“bad” cholesterol. The association between hypercholes-
terolemia and atherosclerosis has long been recognized,
but we now know that a host of other metabolic distur-
bances can potentially augment the effects of choles-
terol. Indeed, the first article on atherosclerosis in AJP
dealt with precisely this topic. Entitled “The Effect of Cer-
tain Metabolic Changes on the Aorta of Rabbits and
Guinea Pigs,” it was written by Otto Saphir.4 (It is note-
worthy how many of the early papers were penned by just
one or two investigators, conjuring up the image of a lone
pathologist hunched over his, or rarely her, microscope
late into the night.) Unfortunately, none of the metabolic
perturbations that Saphir introduced (thyroxine, acidosis,
quinine) resulted in atherosclerotic lesions. Nevertheless,
his article stands as a good example of the early use of
animals to study this disease. In fact, rabbits proved key to
recognizing a causal relationship between hypercholester-
olemia and atherosclerosis, as feeding them a diet rich in fat
produces lesions that are similar (but certainly not identical)
to human atheromas. The cholesterol-fed rabbit features
prominently in a number of studies published in AJP, al-
though its use must have been rather controversial: papers
that used the model abound with statements akin to, “It is
realized that the mechanisms of atherogenesis in the rabbit
may be different from those in man.”5,p877 The desire for a
more faithful mimic of the human disease is evident from the
wide variety of animals examined to this end in AJP publi-
cations. The menagerie reads like a ship’s manifest from
Noah’s ark: rats, swine, chickens, hamsters, dogs, White
Carneau pigeons, a variety of non-human primates, and
even trout have had their vessels sliced and diced in the
quest to recapitulate human atherosclerosis.
The Emergence of Alternative Hypotheses
Several investigators in the 1930s, 1940s, and 1950s in fact
doubted the validity of the cholesterol-fed rabbit model and
openly questioned whether hyperlipidemia had any caus-
ative role in human atherogenesis. Rather, they posited that
lipids might accumulate in lesions secondary to other fac-
tors, such as loss of flexibility of the vessel.6 Zeek7 even
speculated that hypercholesterolemia could be a result of
atherosclerosis, with blood-borne lipids emanating from
ruptured plaques. Another theory from that time, dubbed
the encrustation hypothesis, suggested that plaques grow
primarily due to repeated incorporation of thrombi by the
vascular wall. McLetchie8 put this hypothesis to the test by
inducing clots in rabbits with cobra venom factor. Although
his results were equivocal, organization of thrombi on an
injured vessel wall is still considered one of themechanisms
by which plaque accrues. McLetchie’s concluding remarks,
made in 1952, showed considerable prescience: “The vas-
cular endothelium is (currently) considered to play a pas-
sive role . . . I have doubts about the confinement of the
endothelium to a passive role . . . It appears obvious that
little advance can be made without more precise knowl-
edge of the general biology of blood vessels, in particulartheir reactions to stress and the relationship of the endothe-
lium to the normal fluidity of the blood.”8,p422-424
Despite the limitations of the rabbit model, many inves-
tigators put it to good use, aided by advances in methods
for microscopy in the 1950s. Duff et al9 devised a tech-
nique to view the surface of whole mounts of intact aortic
intima, which permitted analysis of very early lesions in the
cholesterol-fed rabbit. In hindsight, two of their observations
are remarkable. First, they noted that the endothelium over-
lying early lesions appears normal, a foreshadowing of the
idea that endothelial dysfunction, rather than overt damage,
can lead to disease. Second, they observed monocytic
cells on the surface of early lesions and speculated that
such cells crawl through the endothelium to enter the intima,
where collections of so-called histiocytes were observed.
The authors were circumspect regarding identification of
these monocytic cells and ended their article thus: “That
monocytes can enter the tissues, forming phagocytes, is
generally agreed. There is no agreement that lymphocytes
can do so . . . The evidence offered by the present study
does not justify our entering the controversy.”9,p859
Lessons Learned from Electron Microscopy
It would be another 20 years or so before the macro-
phage regained its proper place in the spotlight. In the
meantime, electron microscopy drew attention to another
important cellular player, the smooth muscle cell. In 1960
and 1965, Parker and Odland published integrated stud-
ies examining the evolution of lesions in cholesterol–fed
rabbits via electron microscopy, light microscopy, histo-
chemistry, and biochemistry (to characterize lipids). Most
importantly, they found that lesions are rich in cells that
have the ultrastructural characteristics of smooth muscle
cells.10–12 These investigators were led to conclude that
much of the cellularity in atherosclerotic plaque is in fact
smooth muscle that originated from the media, a then-
radical concept that is now accepted as fact. They also
raised the possibility that many of the characteristic lipid-
laden foam cells in lesions—previously thought to repre-
sent overstuffed macrophages—derived from smooth
muscle cells. Similar conclusions were ultimately reached
by Geer et al13 in their study of the fine structure of
atherosclerotic lesions in human specimens. The con-
temporary interest in this line of investigation is under-
scored by the fact that the paper by Geer and colleagues
was one of the 20 most highly cited in AJP for that de-
cade. Electron microscopy also provided evidence that
endothelial cells in cholesterol-fed rabbits are altered
morphologically, and it was posited that they might be
ferrying lipids into the growing lesions.10–12 Thus, the
stage was set for Ross’s response-to-injury hypothesis;
indeed, Parker and Odland11 ended one of their papers
with the statement, “it would seem that the accumulation
of smooth muscle cells within the intima represents a
response to various types of stimuli, perhaps best gen-
erally characterized as injury.”p211
As mentioned, Ross and colleagues3 outlined their con-
cept of the hypothesis in a review article published in AJP in
1977. At that time, they proposed endothelial denudation as
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gregation of platelets at the damaged site. This view was
based on their in vitro experiments, demonstrating that
platelets elaborate factors that stimulate migration and pro-
liferation of smooth muscle cells. But how did this scenario
fit with observations that the endothelium in early atheromas
often appears intact, even using methods as sensitive as
electron microscopy? Also unresolved were the origin and
role of foam cells and the mechanistic relationships that
could connect hypercholesterolemia, as well as other met-
abolic disturbances (eg, homocysteinemia14 or diabetes),
to atherogenesis. It took another generation of technical
innovations to supply the answers. In particular, advances
in genetic engineering, culture of primary cells, and cellular
imaging led to important breakthroughs.
In terms of imaging, the burgeoning ability to identify
distinct cell types via specific markers proved especially
valuable. In fact, four papers that applied this approach to
atherosclerosis are among the most highly cited AJP arti-
cles of the 1980s.15–18 Considerable evidence had accu-
mulated to suggest that some of the lipid-laden foam cells in
atherosclerotic lesions were in fact smooth muscle cells.
However, a population lacking ultrastructural features of
smooth muscle was also noted.10–13 Schaffner et al15
helped to resolve the origin of foam cells by isolating them
from cholesterol-fed rabbits and monkeys and demonstrat-
ing that many bore receptors for immunoglobulins and
complement proteins and could phagocytize opsonized
red blood cells, all features of macrophages. In experi-
ments using cholesterol-fed swine, electron microscopy
revealed cells with the enzymatic characteristics of
monocytes adhering to endothelium and apparently mi-
grating into the intima of the aorta even before lesions
could be discerned.16 Other investigators used immuno-
cytochemical techniques to delineate the cellular compo-
sition of human atherosclerotic plaques. These studies
made it clear that both macrophages and T lymphocytes
are present in early lesions17 and that substantial num-
bers of plaque-associated T cells display markers of ac-
tivation.18 Improved fixation procedures for electron mi-
croscopy that preserve extracellular lipids refined the
chronology of pathogenesis even further: in cholesterol-
fed rabbits, extracellular fats accumulate in the aortic
intima well before monocytes infiltrate.19
Immune Mechanisms of Injury
At the same time, the accuracy of McLetchie’s prescient
conclusion in 1952 that the endothelium must play more
than a passive role in atherogenesis was becoming in-
creasingly apparent. A 1988 article by Jordan Pober,20
on the occasion of his receiving ASIP’s Warner-Lambert/
Parke-Davis Award, reviewed the growing evidence that
endothelial cells are key players in many immune pro-
cesses, including recruitment of circulating leukocytes.
During this time, significant advances in tissue-culture
techniques permitted dissection of the interactions be-
tween endothelium and monocytes in vitro, without having
to sort through a multitude of confounding variables in the
intact animal. Tissue-culture experiments also furnished ameans for formally testing the direct involvement of lipids
and lipoproteins in atherogenesis and helped to eliminate
any notion that they were merely collateral players. Ac-
cordingly, studies published in AJP using in vitro ap-
proaches demonstrated that cholesterol and low-density
lipoproteins (LDL) directly enhance the adhesion of
monocytes to endothelial cells21,22 and perturb the met-
abolic functions of the latter.23 Moreover, monocytes iso-
lated from hypercholesterolemic rats were shown to pro-
duce factors that attract smooth muscle cells and foster
their proliferation.22 In 1984, Kruth24 reported the pres-
ence of unesterified (free) cholesterol in human athero-
sclerotic lesions, suggesting an important role for free
cholesterol in the development of disease and foreshad-
owing subsequent work that would demonstrate roles for
free cholesterol in inflammation and plaque formation.
By the end of the 1980s, a much clearer picture had
thus emerged of how atheromas are initiated and prog-
ress. In 1993, Russell Ross25 published another review
article in AJP that refined the response-to-injury hypoth-
esis, largely codifying the present-day view of the patho-
genesis of atherosclerosis. The review was based on the
lecture that Dr. Ross delivered on the occasion of receiv-
ing ASIP’s Rous-Whipple Award in recognition of his out-
standing scientific career and contributions to the field.
To quote, “. . . the lesions of atherosclerosis represent a
specialized form of a protective, inflammatory-prolifera-
tive response to various forms of insult to the artery wall.
Depending upon the nature and duration of the insult, the
protective response may become excessive and over
many years in its excess become a disease state.”25,p987
(The emphasis is that of Dr. Ross.).
Future Trajectory of Atherosclerosis Research
Of course, our current picture of atherogenesis is clear only
in broad strokes, and many details still await illumination. As
such, the topic remains of great interest to authors and
readers of AJP. The need for additional animal models that
will enable analysis of the intricacies of the disease is a
recurring theme. The Watanabe rabbit, which lacks LDL
receptors, is a model of human familial hypercholesterol-
emia and is discussed in an AJP article that was part of a
series on animal models of human disease.26 Other recent
papers describe rodent models that incorporate multiple
etiologies, such as diabetes and hypercholesterolemia, to
mirror more closely the complexity that underlies the human
illness.27,28 LDL receptor-deficient mice have been ex-
ploited to assess how lowering lipids affects regression of
early or advanced atherosclerotic lesions.29,30 Notably,
models of atherosclerosis in genetically-engineered mice,
discussed in a 2004 AJP review article,31 have been instru-
mental in dissecting immunological andmolecular details of
pathogenesis andwill be the subject of a future article in this
Centennial series.
Insights provided by basic research—much of it de-
scribed in the pages of AJP over the past century—have
led to a host of effective treatments for atherosclerosis.
Because of the mechanistic link established between
hypercholesterolemia and atherosclerotic disease, st-
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the benefit of some 25 million Americans. That statins
fortuitously also improve endothelial function and reduce
inflammation32,33 was an unanticipated benefit. Never-
theless, the multifactorial nature of atherosclerosis means
that there is still a need to develop additional therapies. A
2008 AJP Review by Lamon and Hajjar34 provides an
excellent summary of the molecular and cellular under-
pinnings of atherogenesis and discusses how these
might be targeted. The article also includes a cogent
discussion of the dietary and socioeconomic changes
that have led to today’s epidemic of cardiovascular dis-
ease. Some of these are potentially amenable to volitional
changes in habits (eg, smoking or diet); others (eg, in-
creased lifespan) are not so easily handled. As the au-
thors point out, genomics, proteomics, and metabolo-
mics may prove key to one day providing personalized
treatment for this complex, still-enigmatic disorder.
Concluding Remarks
This survey of the last 100 years demonstrates that AJP
has been a long-standing and integral collaborator in the
dissemination of our understanding of atherosclerosis.
With its broad focus on cellular and molecular mecha-
nisms of disease encompassing a wealth of model sys-
tems, both in vitro and in vivo, the AJP attracts some of the
best contributions of breakthroughs in the field.
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